Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 29, 2020 - The FDA approved a new Boxed Warning for brand and generic Singulair (montelukast) products regarding the risk of serious neuropsychiatric (NP) events.
Return to publications